查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1983917

医药铝塑管包装市场：2026-2032年全球市场预测（依材料、管材结构、容量范围、产品配方类型、药物类型、生产流程、最终用户类型及治疗应用划分）

Aluminum & Plastic Tube packaging for Pharmaceutical Products Market by Material Type, Tube Structure, Capacity Range, Product Formulation Type, Drug Type, Manufacturing Process, End User Type, Therapeutic Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，医药铝塑管包装市场价值将达到 80.2 亿美元，到 2026 年将成长至 84.2 亿美元，到 2032 年将达到 122.7 亿美元，复合年增长率为 6.26%。

主要市场统计数据
基准年 2025 80.2亿美元
预计年份：2026年 84.2亿美元
预测年份 2032 122.7亿美元
复合年增长率 (%) 6.26%

策略介绍：概述材料创新、更严格的法规和营运整合如何重新定义铝和塑胶管包装选择。

由于材料科学的进步、监管要求的不断变化以及对供应链韧性的日益重视，医药包装行业正处于转折点。铝製和塑胶管仍然是外用和口腔清洁用品药品的主要包装形式，能够为乳膏、凝胶、软膏和糊剂等製剂提供保护、方便给药并延长保质期。目前，製造商和品牌所有者关注的重点包括活性成分与管材的相容性、溶剂和阻隔性能以及包装组件的环境生命週期。

永续发展需求、先进材料科学和重组筹资策略如何共同改变药品管状包装的发展趋势。

由于三大因素的交汇，该行业正经历着变革性的转变：对永续性的需求、材料和瓶盖技术的进步，以及地缘政治摩擦导致的供应链重组。对永续性的需求促使人们重新思考原材料的选择和设计理念。製造商正在加速测试可回收的单一材料软管和混合解决方案，以兼顾阻隔性能和使用后的可回收性。同时，法律规范越来越要求对可回收性声明和材料成分进行清晰的文件记录，这使得生命週期评估和第三方检验在供应商选择中的重要性日益凸显。

系统评估关税变化对管材包装供应链的韧性、筹资策略和材料采购的影响。

2025年实施的新关税环境促使企业重新评估其采购、物流和库存策略，更加重视成本透明度和供应商多元化。关税调整增加了部分进口原材料和零件的到岸成本，导致关键投入品的生产转向近岸外包，并重新关注能够满足监管文件要求和品质预期的国内加工商。近期由此产生的一个营运影响是，企业重新调整了供应商审核和认证流程的优先级，以降低跨境关税波动带来的风险。

全面的细分洞察，将药物类型、材料、容量等级、瓶盖和填充形式与包装性能和营运需求相匹配。

深入的市场区隔能够提供切实可行的观点，帮助我们了解需求驱动因素，并优化包装解决方案，以满足产品和製程要求。在考虑药品类型时，非处方药 (OTC) 和处方药之间的差异会影响监管要求、标籤要求以及与活性成分接触的材料所需的技术检验等级。非处方药通常优先考虑成本效益和广泛的分销相容性，而处方药则往往需要更严格的兼容性和可追溯性文件。

影响包装选择的美洲、欧洲、中东和非洲以及亚太地区的市场动态和供应链特征

在全球医药软管包装的部署中，区域趋势影响筹资策略和产品设计重点。在美洲，重点在于严格的文檔规范以确保符合监管要求，高度重视可回收性声明，以及成熟的契约製造伙伴关係，从而支持快速规模化生产。在北美供应链中，企业越来越倾向于选择能够满足快速交货期限并在材料替代和瓶盖创新方面提供技术合作的区域加工商。

具有竞争力和协作精神的企业策略，强调管状包装的技术伙伴关係、品质保证和永续性可靠性。

随着价值中心从大宗商品供应转向技术伙伴关係和永续发展记录，製造商、加工商和专业供应商之间的竞争日益激烈。主要企业正透过投资阻隔技术、低能耗製造流程以及能够证明产品可回收性和再生材料含量的认证专案来脱颖而出。提供一站式技术支援、法规文件和填充线整合协助的服务型供应商，在与希望加速产品上市并充满信心的製药客户谈判时，正建立起战略优势。

为包装产业的领导者提供切实可行的建议，以加强供应链的韧性和合规性，同时协调采购、创新和永续性。

产业领导企业应采取整合式方法，从产品开发的早期阶段就协调采购、研发和法规遵循团队，以预防合规问题并加快认证週期。将包装因素纳入处方集决策，可减少返工，并确保瓶盖和基材的选择适合预期用途，无论是在零售非处方药分销还是严格控制的处方药配发中。早期协作也有助于与供应商就共同开发机会和工具共用安排进行更有效的对话，从而缩短前置作业时间并降低整体拥有成本。

透过结合初步访谈、技术审查、供应链映射和生命週期评估的严谨研究途径，可以获得关于包装的检验见解。

本调查方法结合了定性和定量方法，旨在全面深入了解目前药品软管包装的现状。初步调查包括对包装工程师、法规专家、采购经理和加工商进行结构化访谈，并辅以现场考察和对填充线及模具製作流程的直接观察。基于这些直接调查结果，我们评估了各种剂型（包括乳膏、凝胶、软膏和糊剂）的材料适用性、瓶盖性能和认证计划。

对技术、监管和供应链要求如何塑造具有韧性和永续的管状包装策略进行了权威总结。

总之，材料创新、监管要求和供应链重组正在相互作用，重新定义铝管和塑胶管在製药应用中的规格製定、采购和合格。相关人员必须推动跨部门合作，确保包装选择能支援产品性能、病患体验和环境目标。对阻隔技术和瓶盖创新进行策略性投资，将有助于产品差异化，同时解决生命週期问题。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：药品用铝管和塑胶管包装市场：依材料类型划分

  • 铝管
    • 未涂层铝管
    • 内涂层铝管
    • 外涂层铝管
  • 塑胶管
    • PE管
      • 低密度聚乙烯管
      • HDPE管材
      • LLDPE管
    • PP管
  • 积层软管
    • ABL管
    • PBL管路

第九章：以管状结构分類的医药铝塑管包装市场

  • 单层管
  • 多层共挤管材
    • 三层管
    • 5层管
    • 7层或更多层管材
  • 层压阻隔管
    • ABL结构
    • PBL结构

第十章：医药用铝管和塑胶管包装市场－依销售范围划分

  • 少于10毫升
  • 10 ml～25 ml
  • 26ml～50ml
  • 51ml～100ml
  • 超过100毫升

第十一章：药品铝製和塑胶管包装市场－依产品配方类型划分

  • 半固态製剂
    • 软膏
    • 奶油
    • 凝胶
    • 贴上
  • 液体
    • 解决方案
    • 悬浮液
    • 乳液

第十二章：药品铝管和塑胶管包装市场－依药品类型划分

  • 处方药
  • 非处方药
  • 学名药
  • 品牌药品
  • 生物製药及特殊药物

第十三章：药品用铝製和塑胶管材包装市场：依製造流程划分

  • 挤压铝管
  • 挤出塑胶管
  • 积层软管製造
  • 射出成型零件

第十四章：以最终用户分類的医药铝管和塑胶管包装市场

  • 製药公司
    • 品牌製药厂商
    • 学名药生产商
  • 合约研发生产组织（CDMO）
  • 合约包装组织
  • 动物用药品生产商
  • 非处方药生产商

第十五章：药品铝製和塑胶管包装市场－依治疗领域划分

  • 皮肤科
  • 眼科
  • 疼痛管理
  • 消化器官系统
  • 呼吸系统
  • 口腔清洁用品
  • 兽医学

第十六章：医药铝塑管包装市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十七章：医药用铝管和塑胶管包装市场：依类别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十八章：药品用铝管及塑胶管包装市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十九章：美国药品铝製及塑胶管包装市场

第二十章：中国医药用铝塑管包装市场

第21章 竞争情势

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Adelphi Healthcare Packaging Limited
  • Albea SA
  • ALLTUB Group BV
  • Almin Extrusion Private Limited
  • Amcor plc
  • Antilla Inc.
  • Aphena Pharma Solutions, Inc.
  • AptarGroup, Inc.
  • Berry Global Group, Inc.
  • BRK Packwell Private Limited
  • CCL Industries Inc.
  • EPL Limited
  • Essentra plc
  • Gerresheimer AG
  • Hoffmann Neopac AG
  • Junsam Packaging Material Co., Ltd.
  • Montebello Packaging Inc.
  • Multitubes Group BV
  • Plastirey SA de CV
  • Sanner GmbH
  • Silgan Holdings Inc.
  • Tekni-Plex, Inc.
  • TUBEX Holding GmbH
  • Victor Packaging, Inc.
Product Code: MRR-A0184B3CF206

The Aluminum & Plastic Tube packaging for Pharmaceutical Products Market was valued at USD 8.02 billion in 2025 and is projected to grow to USD 8.42 billion in 2026, with a CAGR of 6.26%, reaching USD 12.27 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 8.02 billion
Estimated Year [2026] USD 8.42 billion
Forecast Year [2032] USD 12.27 billion
CAGR (%) 6.26%

A strategic introduction framing how material innovation, regulatory rigor, and operational integration are redefining aluminum and plastic tube packaging choices

The pharmaceutical packaging landscape has reached an inflection point driven by material science advances, evolving regulatory expectations, and heightened scrutiny of supply-chain resilience. Aluminum and plastic tubes remain core delivery formats for topical and oral care pharmaceuticals, offering protection, dosing convenience, and extended shelf life for cream, gel, ointment, and paste formulations. Near-term priorities for manufacturers and brand owners include compatibility of active ingredients with tube substrates, solvent and barrier performance, and the environmental lifecycle of packaging components.

Recent product innovation has emphasized not only barrier integrity and dosing accuracy but also secondary attributes such as printability for lot and regulatory information, tactile experience for patient adherence, and compatibility with automated filling lines. These operational considerations intersect with sustainability targets as firms reassess single-use plastics, aluminum reclamation pathways, and the viability of mono-material constructions. Consequently, procurement, R&D, and regulatory affairs teams are increasingly collaborating to align packaging specifications with clinical and commercial product strategies.

Transitioning from traditional sourcing practices, stakeholders now seek closer integration with converters and material suppliers to accelerate qualification of alternative substrates and closures. The result is a more iterative development cycle in which early-stage packaging decisions are treated as substantive contributors to product performance and cost to serve. This introduction frames the critical trade-offs and decision axes that companies must navigate today to ensure product integrity, regulatory compliance, and market competitiveness.

How sustainability imperatives, advanced material science, and reshaped sourcing strategies are jointly transforming pharmaceutical tube packaging dynamics

The sector is experiencing transformative shifts driven by three converging forces: sustainability mandates, technological advancements in materials and closures, and supply-chain realignment prompted by geopolitical friction. Sustainability mandates are reshaping raw-material choices and design philosophy. Manufacturers are accelerating trials of recyclable mono-material tubes and hybrid solutions that balance barrier performance with end-of-life recovery. Meanwhile, regulatory frameworks increasingly expect clear documentation of recyclability claims and material composition, which has elevated the role of lifecycle assessments and third-party verification in supplier selection.

Material science has delivered notable improvements in multilayer extrusion and barrier coatings that permit thinner walls and reduced material weight while preserving protection for sensitive formulations. Closures have evolved beyond simple mechanical seals to incorporate precision dispensing and child-resistant functionality where required, supported by tighter tolerances and higher fill-line accuracy on modern filling lines. These innovations reduce product waste and improve patient experience, but they also demand updated qualification protocols and closer collaboration between formulators and packaging engineers.

Supply-chain realignment has altered sourcing strategies. Companies are balancing cost pressures with a desire for redundancy by developing regional supplier relationships, qualified alternate converters, and inventory-buffer strategies that mitigate single-source risks. This shift encourages longer-term commercial agreements and joint investment in capacity or tooling shared across product portfolios. As stakeholders adapt, decision-making increasingly favors partners capable of offering technical support, regulatory documentation, and demonstrable sustainability credentials alongside competitive lead times.

Assessing the systemic consequences of tariff shifts on supply-chain resilience, procurement strategy, and material sourcing for tube packaging

The tariff landscape introduced in 2025 has led companies to re-evaluate procurement, logistics, and inventory strategies with an emphasis on cost transparency and supplier diversification. Tariff-related adjustments have increased landed costs for certain imported substrates and components, prompting a shift toward nearshoring for critical inputs and a renewed focus on domestic converters capable of meeting regulatory documentation and quality expectations. The immediate operational consequence has been a re-prioritization of supplier audits and qualification pipelines to reduce exposure to cross-border tariff volatility.

In response, manufacturers have intensified efforts to validate alternative materials and to renegotiate commercial terms that absorb some tariff-induced cost increases. The dynamic has also accelerated investment in inventory optimization and demand-smoothing mechanisms to avoid production interruptions tied to import delays. Moreover, the tariff environment has amplified the importance of robust cost-engineering practices, pushing packaging and procurement teams to identify design efficiencies and to collaborate on tool standardization that can lower unit conversion costs over time.

Regulatory compliance and customs classification have taken on greater strategic significance, as proper tariff classifications and documentation can materially affect landed costs and clearance times. Consequently, legal and compliance functions have become more involved in packaging sourcing decisions, ensuring that material specifications, country-of-origin declarations, and preferential trade program eligibility are fully assessed. Overall, the tariff developments have reshaped risk assessment frameworks, steering the industry toward more diversified supply footprints, closer supplier partnerships, and a disciplined focus on total cost of ownership rather than purely unit price.

Comprehensive segmentation insights that align drug types, materials, volume classes, closures, and filling forms with packaging performance and operational needs

Insightful segmentation provides a practical lens for understanding demand drivers and tailoring packaging solutions to product and process requirements. When examined by drug type, distinctions between over-the-counter formulations and prescription products influence regulatory expectations, labeling requirements, and often the level of technical verification demanded for materials in contact with actives. Over-the-counter products commonly emphasize cost efficiency and broad distribution compatibility, whereas prescription drugs frequently require more rigorous documentation of compatibility and traceability.

Material type segmentation highlights a fundamental trade-off between aluminum and plastic substrates. Aluminum offers established barrier performance and recyclability pathways, particularly suited to sensitive formulations and high-barrier requirements, while plastic variants enable economical, lightweight constructions and compatibility with diverse closure systems. Volume range segmentation reveals that tubes sized 51 to 100 milliliter and above 100 milliliter serve different channel and dosing requirements compared with smaller formats. Up to 50 milliliter tubes, especially those in 21 to 50 milliliter or up to 20 milliliter subranges, are tailored for portability, sample distribution, and patient adherence, and thus often prioritize tactile design, tamper evidence, and compatibility with smaller-scale filling systems.

Closure type segmentation identifies important interface considerations between container and user, with flip top, screw cap, and snap cap options delivering distinct user experiences, re-seal performance, and fill-line compatibility. Flip top closures support single-handed dispensing and everyday convenience, screw caps offer robust sealing for longer-term storage, and snap caps provide cost-effective sealing with rapid access for frequent use. Filling form segmentation-covering cream, gel, ointment, and paste-dictates substrate selection, wall thickness, and closure design due to differences in viscosity, shear sensitivity, and interaction with inner coatings. Taken together, these segmentation dimensions inform design optimization, supplier selection, and quality assurance protocols to ensure alignment between product characteristics and packaging performance.

Regional market dynamics and supply-chain attributes across the Americas, Europe Middle East & Africa, and Asia-Pacific that influence packaging choices

Regional dynamics shape both sourcing strategies and product design priorities across the global footprint of pharmaceutical tube packaging. The Americas region emphasizes regulatory compliance with stringent documentation practices, strong emphasis on recyclability claims, and maturity in contract manufacturing partnerships that support rapid scale-up. North American supply chains display a growing preference for regional converters that can provide quick turnarounds and technical collaboration on material substitution and closure innovation.

The Europe, Middle East & Africa region combines high regulatory rigor with advanced circular-economy initiatives that drive adoption of certified recycling streams and mono-material designs. European regulators and industry bodies have accelerated requirements for accurate recyclability communication, which in turn pushes suppliers to prioritize validated recovery solutions and low-impact material choices. Meanwhile, the Middle East and Africa present opportunities for capacity expansion and localized packaging solutions that address climatic considerations and channel-specific distribution challenges.

Asia-Pacific remains a center of manufacturing scale and rapid innovation, balancing cost competitiveness with increasing attention to sustainability and compliance. The region hosts a broad spectrum of converters capable of high-volume production and sophisticated multilayer extrusion, while also seeing growth in regionally focused suppliers that offer rapid prototyping and tooling services. Across all regions, effective market participation depends on aligning supplier capabilities with regional regulatory expectations, environmental initiatives, and the specific channel requirements of formulators and brand owners.

Competitive and collaborative company strategies emphasizing technical partnerships, quality assurance, and sustainability credentials in tube packaging

Competitive dynamics among manufacturers, converters, and specialty suppliers are intensifying as value shifts from commodity supply toward technical partnership and sustainability credentials. Key players differentiate through investments in barrier technologies, low-energy manufacturing processes, and certification programs that validate recyclability or recycled content. Service-oriented providers that bundle technical support, regulatory documentation, and fill-line integration assistance command a strategic advantage in conversations with pharmaceutical clients looking to accelerate time-to-market with confidence.

Collaborative innovation models have become more common, with formulators co-developing materials and closures to solve specific compatibility challenges or to reduce environmental impact. Strategic alliances, joint ventures, and co-investments in tooling and pilot capacity enable faster qualification of new substrates and permit shared risk across multiple product launches. At the same time, smaller specialty converters are carving niches by offering bespoke formulations for inner coatings, rapid prototyping, and agility in low-to-medium volume production runs that larger plants may not economically support.

Quality systems, supply continuity assurances, and traceability capabilities are decisive selection criteria for clients in regulated markets. Suppliers that provide robust documentation packages-covering material origin, compatibility testing, and batch traceability-are positioned to win long-term contracts. In addition, firms that can demonstrate continuous improvement in energy use, waste reduction, and circular design principles strengthen their competitive proposition as brand owners push sustainability agendas across their entire product portfolios.

Actionable recommendations for packaging leaders to align procurement, innovation, and sustainability while strengthening supply-chain resilience and compliance

Industry leaders should pursue an integrated approach that aligns procurement, R&D, and regulatory teams early in product development to preempt compatibility issues and accelerate qualification cycles. Embedding packaging considerations into formulary decisions will reduce rework and ensure that closure and substrate choices complement the intended use case, whether for retail over-the-counter distribution or tightly controlled prescription dispensing. Early alignment also enables more effective dialogue with suppliers on co-development opportunities and tool-sharing arrangements that can reduce lead times and total cost of ownership.

Leaders should prioritize supplier diversification and regional qualification to insulate operations from tariff exposure and logistic disruptions. Establishing a primary and secondary supplier footprint with cross-qualified tooling or validated alternative materials will enhance resilience without sacrificing product integrity. Concurrently, investing in barrier technology trials and lifecycle assessments will help identify opportunities to transition to mono-material constructions or to incorporate higher recycled content while maintaining compatibility with creams, gels, ointments, and pastes.

Finally, companies must elevate documentation and traceability as core capabilities. Comprehensive material data packages, compatibility evidence, and clear recyclability claims not only support regulatory compliance but also strengthen commercial positioning with sustainability-focused customers. By coupling these internal initiatives with strategic partnerships for pilot production, testing, and certification, industry leaders can accelerate innovation, reduce risk, and create demonstrable value for stakeholders across the supply chain.

A rigorous research approach combining primary interviews, technical review, supply-chain mapping, and lifecycle assessment to produce validated packaging insights

The research methodology combines qualitative and quantitative techniques to ensure a robust, multi-faceted understanding of the pharmaceutical tube packaging landscape. Primary research consisted of structured interviews with packaging engineers, regulatory specialists, procurement leaders, and converters, complemented by site visits and direct observation of filling lines and tooling operations. These firsthand insights informed assessments of material compatibility, closure performance, and qualification timelines across different filling forms such as cream, gel, ointment, and paste.

Secondary research integrated technical literature, patent filings, trade data, and regulatory guidance to map material innovations, barrier technologies, and certification programs. Comparative analysis of manufacturing processes, from aluminum drawing and annealing to plastic extrusion and lamination, provided context for quality control practices and potential failure modes. The methodology also included lifecycle and recyclability assessments using established environmental frameworks to evaluate end-of-life considerations for aluminum and plastic constructions.

Data validation occurred through triangulation across sources and iterative expert review, ensuring that findings reflect current operational realities and emerging trends. Expert panels provided feedback loops to refine conclusions and to prioritize recommendations. Together, these approaches produced a comprehensive, evidence-based picture of technological trajectories, supplier capabilities, and the practical trade-offs that manufacturers face when selecting tube formats and closure systems for regulated pharmaceutical applications.

A conclusive synthesis of how technical, regulatory, and supply-chain imperatives are shaping resilient and sustainable tube packaging strategies

In conclusion, the interplay of material innovation, regulatory expectations, and supply-chain realignment is redefining how aluminum and plastic tubes are specified, sourced, and qualified for pharmaceutical use. Stakeholders must embrace cross-functional collaboration to ensure that packaging choices support product performance, patient experience, and environmental objectives. Strategic investment in barrier technologies and closure innovations will enable product differentiation while addressing lifecycle concerns.

At the same time, evolving trade dynamics and tariff considerations have underscored the need for diversified supplier networks and meticulous documentation to sustain production continuity. Firms that proactively incorporate sustainability metrics, robust traceability, and supplier qualification strategies into their packaging programs will be better positioned to manage risk and to meet the evolving expectations of regulators and end customers. The path forward favors organizations that combine technical rigor with agile procurement and collaborative supplier relationships to deliver safe, compliant, and sustainable packaging solutions.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Aluminum & Plastic Tube packaging for Pharmaceutical Products Market, by Material Type

  • 8.1. Aluminum Tubes
    • 8.1.1. Uncoated Aluminum Tubes
    • 8.1.2. Internal Coated Aluminum Tubes
    • 8.1.3. External Coated Aluminum Tubes
  • 8.2. Plastic Tubes
    • 8.2.1. PE Tubes
      • 8.2.1.1. LDPE Tubes
      • 8.2.1.2. HDPE Tubes
      • 8.2.1.3. LLDPE Tubes
    • 8.2.2. PP Tubes
  • 8.3. Laminated Tubes
    • 8.3.1. ABL Tubes
    • 8.3.2. PBL Tubes

9. Aluminum & Plastic Tube packaging for Pharmaceutical Products Market, by Tube Structure

  • 9.1. Monolayer Tubes
  • 9.2. Multi-Layer Co-Extruded Tubes
    • 9.2.1. 3-Layer Tubes
    • 9.2.2. 5-Layer Tubes
    • 9.2.3. 7-Layer And Above Tubes
  • 9.3. Laminated Barrier Tubes
    • 9.3.1. ABL Structure
    • 9.3.2. PBL Structure

10. Aluminum & Plastic Tube packaging for Pharmaceutical Products Market, by Capacity Range

  • 10.1. Less Than 10 ml
  • 10.2. 10 ml To 25 ml
  • 10.3. 26 ml To 50 ml
  • 10.4. 51 ml To 100 ml
  • 10.5. Above 100 ml

11. Aluminum & Plastic Tube packaging for Pharmaceutical Products Market, by Product Formulation Type

  • 11.1. Semi-Solid Dosage
    • 11.1.1. Ointments
    • 11.1.2. Creams
    • 11.1.3. Gels
    • 11.1.4. Pastes
  • 11.2. Liquid Dosage
    • 11.2.1. Solutions
    • 11.2.2. Suspensions
    • 11.2.3. Emulsions

12. Aluminum & Plastic Tube packaging for Pharmaceutical Products Market, by Drug Type

  • 12.1. Prescription Drugs
  • 12.2. Over-The-Counter Drugs
  • 12.3. Generic Drugs
  • 12.4. Branded Drugs
  • 12.5. Biologics & Specialty Drugs

13. Aluminum & Plastic Tube packaging for Pharmaceutical Products Market, by Manufacturing Process

  • 13.1. Extruded Aluminum Tubes
  • 13.2. Extruded Plastic Tubes
  • 13.3. Laminated Tube Manufacturing
  • 13.4. Injection Molded Components

14. Aluminum & Plastic Tube packaging for Pharmaceutical Products Market, by End User Type

  • 14.1. Pharmaceutical Manufacturers
    • 14.1.1. Branded Pharmaceutical Companies
    • 14.1.2. Generic Pharmaceutical Companies
  • 14.2. Contract Development And Manufacturing Organizations
  • 14.3. Contract Packaging Organizations
  • 14.4. Veterinary Pharmaceutical Companies
  • 14.5. Over-The-Counter Healthcare Companies

15. Aluminum & Plastic Tube packaging for Pharmaceutical Products Market, by Therapeutic Application

  • 15.1. Dermatology
  • 15.2. Ophthalmology
  • 15.3. Pain Management
  • 15.4. Gastrointestinal
  • 15.5. Respiratory
  • 15.6. Oral Care
  • 15.7. Veterinary

16. Aluminum & Plastic Tube packaging for Pharmaceutical Products Market, by Region

  • 16.1. Americas
    • 16.1.1. North America
    • 16.1.2. Latin America
  • 16.2. Europe, Middle East & Africa
    • 16.2.1. Europe
    • 16.2.2. Middle East
    • 16.2.3. Africa
  • 16.3. Asia-Pacific

17. Aluminum & Plastic Tube packaging for Pharmaceutical Products Market, by Group

  • 17.1. ASEAN
  • 17.2. GCC
  • 17.3. European Union
  • 17.4. BRICS
  • 17.5. G7
  • 17.6. NATO

18. Aluminum & Plastic Tube packaging for Pharmaceutical Products Market, by Country

  • 18.1. United States
  • 18.2. Canada
  • 18.3. Mexico
  • 18.4. Brazil
  • 18.5. United Kingdom
  • 18.6. Germany
  • 18.7. France
  • 18.8. Russia
  • 18.9. Italy
  • 18.10. Spain
  • 18.11. China
  • 18.12. India
  • 18.13. Japan
  • 18.14. Australia
  • 18.15. South Korea

19. United States Aluminum & Plastic Tube packaging for Pharmaceutical Products Market

20. China Aluminum & Plastic Tube packaging for Pharmaceutical Products Market

21. Competitive Landscape

  • 21.1. Market Concentration Analysis, 2025
    • 21.1.1. Concentration Ratio (CR)
    • 21.1.2. Herfindahl Hirschman Index (HHI)
  • 21.2. Recent Developments & Impact Analysis, 2025
  • 21.3. Product Portfolio Analysis, 2025
  • 21.4. Benchmarking Analysis, 2025
  • 21.5. Adelphi Healthcare Packaging Limited
  • 21.6. Albea S.A.
  • 21.7. ALLTUB Group B.V.
  • 21.8. Almin Extrusion Private Limited
  • 21.9. Amcor plc
  • 21.10. Antilla Inc.
  • 21.11. Aphena Pharma Solutions, Inc.
  • 21.12. AptarGroup, Inc.
  • 21.13. Berry Global Group, Inc.
  • 21.14. BRK Packwell Private Limited
  • 21.15. CCL Industries Inc.
  • 21.16. EPL Limited
  • 21.17. Essentra plc
  • 21.18. Gerresheimer AG
  • 21.19. Hoffmann Neopac AG
  • 21.20. Junsam Packaging Material Co., Ltd.
  • 21.21. Montebello Packaging Inc.
  • 21.22. Multitubes Group B.V.
  • 21.23. Plastirey S.A. de C.V.
  • 21.24. Sanner GmbH
  • 21.25. Silgan Holdings Inc.
  • 21.26. Tekni-Plex, Inc.
  • 21.27. TUBEX Holding GmbH
  • 21.28. Victor Packaging, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY TUBE STRUCTURE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY CAPACITY RANGE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY PRODUCT FORMULATION TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY DRUG TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY MANUFACTURING PROCESS, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY END USER TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 15. UNITED STATES ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 16. CHINA ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY ALUMINUM TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY ALUMINUM TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY ALUMINUM TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY ALUMINUM TUBES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY UNCOATED ALUMINUM TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY UNCOATED ALUMINUM TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY UNCOATED ALUMINUM TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY INTERNAL COATED ALUMINUM TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY INTERNAL COATED ALUMINUM TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY INTERNAL COATED ALUMINUM TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY EXTERNAL COATED ALUMINUM TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY EXTERNAL COATED ALUMINUM TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY EXTERNAL COATED ALUMINUM TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY PLASTIC TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY PLASTIC TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY PLASTIC TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY PLASTIC TUBES, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY PE TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY PE TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY PE TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY PE TUBES, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY LDPE TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY LDPE TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY LDPE TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY HDPE TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY HDPE TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY HDPE TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY LLDPE TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY LLDPE TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY LLDPE TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY PP TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY PP TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY PP TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY LAMINATED TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY LAMINATED TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY LAMINATED TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY LAMINATED TUBES, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY ABL TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY ABL TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY ABL TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY PBL TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY PBL TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY PBL TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY TUBE STRUCTURE, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY MONOLAYER TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY MONOLAYER TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY MONOLAYER TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY MULTI-LAYER CO-EXTRUDED TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY MULTI-LAYER CO-EXTRUDED TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY MULTI-LAYER CO-EXTRUDED TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY MULTI-LAYER CO-EXTRUDED TUBES, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY 3-LAYER TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY 3-LAYER TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY 3-LAYER TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY 5-LAYER TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY 5-LAYER TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY 5-LAYER TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY 7-LAYER AND ABOVE TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY 7-LAYER AND ABOVE TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY 7-LAYER AND ABOVE TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY LAMINATED BARRIER TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY LAMINATED BARRIER TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY LAMINATED BARRIER TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY LAMINATED BARRIER TUBES, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY ABL STRUCTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY ABL STRUCTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY ABL STRUCTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY PBL STRUCTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY PBL STRUCTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY PBL STRUCTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY CAPACITY RANGE, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY LESS THAN 10 ML, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY LESS THAN 10 ML, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY LESS THAN 10 ML, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY 10 ML TO 25 ML, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY 10 ML TO 25 ML, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY 10 ML TO 25 ML, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY 26 ML TO 50 ML, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY 26 ML TO 50 ML, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY 26 ML TO 50 ML, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY 51 ML TO 100 ML, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY 51 ML TO 100 ML, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY 51 ML TO 100 ML, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY ABOVE 100 ML, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY ABOVE 100 ML, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY ABOVE 100 ML, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY PRODUCT FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY SEMI-SOLID DOSAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY SEMI-SOLID DOSAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY SEMI-SOLID DOSAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY SEMI-SOLID DOSAGE, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY OINTMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY OINTMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY OINTMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY CREAMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY CREAMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY CREAMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY GELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY GELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY GELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY PASTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY PASTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY PASTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY LIQUID DOSAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY LIQUID DOSAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY LIQUID DOSAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY LIQUID DOSAGE, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY SOLUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY SOLUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY SOLUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY SUSPENSIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY SUSPENSIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY SUSPENSIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY EMULSIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY EMULSIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY EMULSIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY PRESCRIPTION DRUGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY PRESCRIPTION DRUGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY PRESCRIPTION DRUGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY OVER-THE-COUNTER DRUGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY OVER-THE-COUNTER DRUGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY OVER-THE-COUNTER DRUGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY GENERIC DRUGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY GENERIC DRUGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY GENERIC DRUGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY BRANDED DRUGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY BRANDED DRUGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY BRANDED DRUGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY BIOLOGICS & SPECIALTY DRUGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY BIOLOGICS & SPECIALTY DRUGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY BIOLOGICS & SPECIALTY DRUGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY EXTRUDED ALUMINUM TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY EXTRUDED ALUMINUM TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY EXTRUDED ALUMINUM TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY EXTRUDED PLASTIC TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY EXTRUDED PLASTIC TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY EXTRUDED PLASTIC TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY LAMINATED TUBE MANUFACTURING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY LAMINATED TUBE MANUFACTURING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY LAMINATED TUBE MANUFACTURING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY INJECTION MOLDED COMPONENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY INJECTION MOLDED COMPONENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY INJECTION MOLDED COMPONENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY END USER TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY PHARMACEUTICAL MANUFACTURERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY PHARMACEUTICAL MANUFACTURERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY PHARMACEUTICAL MANUFACTURERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY PHARMACEUTICAL MANUFACTURERS, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY BRANDED PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY BRANDED PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY BRANDED PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY GENERIC PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY GENERIC PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY GENERIC PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY CONTRACT PACKAGING ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 163. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY CONTRACT PACKAGING ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY CONTRACT PACKAGING ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY VETERINARY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 166. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY VETERINARY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY VETERINARY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY OVER-THE-COUNTER HEALTHCARE COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 169. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY OVER-THE-COUNTER HEALTHCARE COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 170. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY OVER-THE-COUNTER HEALTHCARE COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 172. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY DERMATOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY DERMATOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 174. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY DERMATOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 176. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY OPHTHALMOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 177. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY OPHTHALMOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 179. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY PAIN MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 180. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY PAIN MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY GASTROINTESTINAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 182. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY GASTROINTESTINAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 183. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY GASTROINTESTINAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY RESPIRATORY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 185. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY RESPIRATORY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 186. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY RESPIRATORY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY ORAL CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 188. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY ORAL CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 189. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY ORAL CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY VETERINARY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 191. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY VETERINARY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 192. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY VETERINARY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 194. AMERICAS ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 195. AMERICAS ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. AMERICAS ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY ALUMINUM TUBES, 2018-2032 (USD MILLION)
  • TABLE 197. AMERICAS ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY PLASTIC TUBES, 2018-2032 (USD MILLION)
  • TABLE 198. AMERICAS ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY PE TUBES, 2018-2032 (USD MILLION)
  • TABLE 199. AMERICAS ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY LAMINATED TUBES, 2018-2032 (USD MILLION)
  • TABLE 200. AMERICAS ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY TUBE STRUCTURE, 2018-2032 (USD MILLION)
  • TABLE 201. AMERICAS ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY MULTI-LAYER CO-EXTRUDED TUBES, 2018-2032 (USD MILLION)
  • TABLE 202. AMERICAS ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY LAMINATED BARRIER TUBES, 2018-2032 (USD MILLION)
  • TABLE 203. AMERICAS ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY CAPACITY RANGE, 2018-2032 (USD MILLION)
  • TABLE 204. AMERICAS ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY PRODUCT FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 205. AMERICAS ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY SEMI-SOLID DOSAGE, 2018-2032 (USD MILLION)
  • TABLE 206. AMERICAS ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY LIQUID DOSAGE, 2018-2032 (USD MILLION)
  • TABLE 207. AMERICAS ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 208. AMERICAS ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2032 (USD MILLION)
  • TABLE 209. AMERICAS ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY END USER TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. AMERICAS ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY PHARMACEUTICAL MANUFACTURERS, 2018-2032 (USD MILLION)
  • TABLE 211. AMERICAS ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 212. NORTH AMERICA ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 213. NORTH AMERICA ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. NORTH AMERICA ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY ALUMINUM TUBES, 2018-2032 (USD MILLION)
  • TABLE 215. NORTH AMERICA ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY PLASTIC TUBES, 2018-2032 (USD MILLION)
  • TABLE 216. NORTH AMERICA ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY PE TUBES, 2018-2032 (USD MILLION)
  • TABLE 217. NORTH AMERICA ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY LAMINATED TUBES, 2018-2032 (USD MILLION)
  • TABLE 218. NORTH AMERICA ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY TUBE STRUCTURE, 2018-2032 (USD MILLION)
  • TABLE 219. NORTH AMERICA ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY MULTI-LAYER CO-EXTRUDED TUBES, 2018-2032 (USD MILLION)
  • TABLE 220. NORTH AMERICA ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY LAMINATED BARRIER TUBES, 2018-2032 (USD MILLION)
  • TABLE 221. NORTH AMERICA ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY CAPACITY RANGE, 2018-2032 (USD MILLION)
  • TABLE 222. NORTH AMERICA ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY PRODUCT FO